US Retinal Vein Occlusion Market

US Retinal Vein Occlusion Market Research Report Information By Type (Branch Retinal Artery Occlusion and Central Retinal Vein Occlusion), By Condition (Non-Ischemic and Ischemic), Diagnosis (Optical Coherence Tomography, Fundoscopic Examination and Fluorescein Angiography), Treatment (Antivascular Endothelial Growth Factor, Corticosteroid Drugs and Laser Retinal Photocoagulation), End User (Hospitals and Clinics and Research & Academics Centers) - Forecast till 2030

ID: MRFR/Pharma/11747-US | 100 Pages | Author: MRFR Research Team | December 2023         

Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid

In the market for retinal vein occlusion, there are two main types: branch retinal artery occlusion and central retinal vein occlusion. Branch retinal artery occlusion is the most commonly used type, making up the largest part of the market in 2016. The second most common type is central retinal vein occlusion, and it is expected to grow at a rate of 10.7% from 2017 to 2023.

Now, let's break it down a bit more. The retinal vein occlusion market is also divided based on the condition of the eye. There are two conditions: non-ischemic and ischemic. Non-ischemic made up the most significant portion of the market in 2016, accounting for 62.3%. Looking ahead, the global market for retinal vein occlusion, considering these conditions, is expected to reach a value of USD 15,889.59 million by 2023. The market is projected to grow at a rate of 11.2% during the forecast period from 2017 to 2023.

In simple terms, when we talk about the types of retinal vein occlusion, there are two main ones: branch retinal artery occlusion and central retinal vein occlusion. The first type is used more often, and the second type is expected to grow at a certain rate. Now, when we look at the conditions of the eye in this market, there are two: non-ischemic and ischemic. The first condition was more common in 2016. Looking into the future, the overall global market for retinal vein occlusion, considering these types and conditions, is predicted to reach a value of USD 15,889.59 million by 2023, growing at a rate of 11.2%.